Dexter, MI, United States of America

Mel C Schroeder

USPTO Granted Patents = 29 

Average Co-Inventor Count = 3.8

ph-index = 13

Forward Citations = 658(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (1986)
  • Dexter, MI (US) (1990 - 2009)

Company Filing History:


Years Active: 1986-2009

Loading Chart...
29 patents (USPTO):Explore Patents

Title: Innovations and Impact of Mel C. Schroeder in Pharmaceutical Patents

Introduction: Mel C. Schroeder is an accomplished inventor based in Dexter, Michigan, who holds an impressive portfolio of 29 patents. His work primarily focuses on the development of innovative compounds aimed at treating various cell proliferative disorders, including cancer. Schroeder's contributions to medicine have had significant implications in the fields of oncology and vascular diseases.

Latest Patents: Among his latest patented inventions are compounds like Bicyclic pyrimidines and bicyclic 3,4-dihydropyprimidines, which act as inhibitors of cellular proliferation. This invention holds promise for treating an array of conditions such as cancer, restenosis, angiogenesis, and atherosclerosis. The formulation includes a variety of substituted pyrimido-pyrimidines that showcase potential therapeutic effects.

Additionally, Schroeder has developed kinase inhibitors, which encompass phenyl-substituted pyrimidopyrimidines and dihydropyrimido-pyrimidines, targeting cyclin-dependent kinase and tyrosine kinase enzymes. This innovative approach not only offers methods for synthesizing these compounds but also presents pharmaceutical compositions designed for treating disorders related to cell proliferation.

Career Highlights: Throughout his career, Schroeder has made significant strides in pharmaceutical research, contributing to numerous advancements in the industry. His tenure at Warner-Lambert Company allowed him to leverage his skills in drug development, ultimately leading to the patented inventions that underscore his career.

Collaborations: Mel C. Schroeder has collaborated with notable professionals such as John S. Kiely and Sheila H. DeWitt. These partnerships have enriched his research endeavors, furthering the impact of his inventions in the pharmaceutical landscape.

Conclusion: Mel C. Schroeder's innovative contributions have not only enhanced the understanding of cellular mechanisms but have also provided foundational tools for addressing serious health issues. With 29 patents to his name, his work continues to influence the development of therapeutic strategies, emphasizing the critical role of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…